In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Captive Primate Safety Act''.

SEC. 2. ADDITION OF NONHUMAN PRIMATES TO DEFINITION OF PROHIBITED 
              WILDLIFE SPECIES.

    Section 2(g) of the Lacey Act Amendments of 1981 (16 U.S.C. 
3371(g)) is amended by inserting before the period at the end ``or any 
nonhuman primate''.

SEC. 3. CAPTIVE WILDLIFE AMENDMENTS.

    (a) Prohibited Acts.--Section 3 of the Lacey Act Amendments of 1981 
(16 U.S.C. 3372) is amended--
            (1) in subsection (a)--
                    (A) in paragraph (2)--
                            (i) in subparagraph (A), by inserting 
                        ``or'' after the semicolon;
                            (ii) in subparagraph (B)(iii), by striking 
                        ``; or'' and inserting a semicolon; and
                            (iii) by striking subparagraph (C); and
                    (B) in paragraph (4), by inserting ``or subsection 
                (e)'' before the period; and
            (2) in subsection (e)--
                    (A) by redesignating paragraphs (2), (3), (4), and 
                (5) as paragraphs (3), (4), (5), and (6) respectively;
                    (B) by striking ``(e)'' and all that follows 
                through ``Subsection (a)(2)(C) does not apply'' in 
                paragraph (1) and inserting the following:
    ``(e) Captive Wildlife Offense.--
            ``(1) In general.--It is unlawful for any person to import, 
        export, transport, sell, receive, acquire, or purchase in 
        interstate or foreign commerce any live animal of any 
        prohibited wildlife species.
            ``(2) Limitation on application.--This subsection--
                    ``(A) does not apply to a person transporting a 
                nonhuman primate to or from a veterinarian who is 
                licensed to practice veterinary medicine within the 
                United States, solely for the purpose of providing 
                veterinary care to the nonhuman primate, if--
                            ``(i) the person transporting the nonhuman 
                        primate carries written documentation issued by 
                        the veterinarian, including the appointment 
                        date and location;
                            ``(ii) the nonhuman primate is transported 
                        in a secure enclosure appropriate for that 
                        species of primate;
                            ``(iii) the nonhuman primate has no contact 
                        with any other animals or members of the 
                        public, other than the veterinarian and other 
                        authorized medical personnel providing 
                        veterinary care; and
                            ``(iv) such transportation and provision of 
                        veterinary care is in accordance with all 
                        otherwise applicable State and local laws, 
                        regulations, permits, and health certificates;
                    ``(B) does not apply to a person transporting a 
                nonhuman primate to a legally designated caregiver for 
                the nonhuman primate as a result of the death of the 
                preceding owner of the nonhuman primate, if--
                            ``(i) the person transporting the nonhuman 
                        primate is carrying legal documentation to 
                        support the need for transporting the nonhuman 
                        primate to the legally designated caregiver;
                            ``(ii) the nonhuman primate is transported 
                        in a secure enclosure appropriate for the 
                        species;
                            ``(iii) the nonhuman primate has no contact 
                        with any other animals or members of the public 
                        while being transported to the legally 
                        designated caregiver; and
                            ``(iv) all applicable State and local 
                        restrictions on such transport, and all 
                        applicable State and local requirements for 
                        permits or health certificates, are complied 
                        with;
                    ``(C) does not apply to a person transporting a 
                nonhuman primate solely for the purpose of assisting an 
                individual who is permanently disabled with a severe 
                mobility impairment, if--
                            ``(i) the nonhuman primate is a single 
                        animal of the genus Cebus;
                            ``(ii) the nonhuman primate was obtained 
                        from, and trained at, a licensed nonprofit 
                        organization described in section 501(c)(3) of 
                        the Internal Revenue Code of 1986 the nonprofit 
                        tax status of which was obtained--
                                    ``(I) before July 18, 2008; and
                                    ``(II) on the basis that the 
                                mission of the organization is to 
                                improve the quality of life of severely 
                                mobility-impaired individuals;
                            ``(iii) the person transporting the 
                        nonhuman primate is a specially trained 
                        employee or agent of a nonprofit organization 
                        described in clause (ii) that is transporting 
                        the nonhuman primate to or from a designated 
                        individual who is permanently disabled with a 
                        severe mobility impairment, or to or from a 
                        licensed foster care home providing specialty 
                        training of the nonhuman primate solely for 
                        purposes of assisting an individual who is 
                        permanently disabled with severe mobility 
                        impairment;
                            ``(iv) the person transporting the nonhuman 
                        primate carries documentation from the 
                        applicable nonprofit organization that includes 
                        the name of the designated individual referred 
                        to in clause (iii);
                            ``(v) the nonhuman primate is transported 
                        in a secure enclosure that is appropriate for 
                        that species;
                            ``(vi) the nonhuman primate has no contact 
                        with any animal or member of the public, other 
                        than the designated individual referred to in 
                        clause (iii); and
                            ``(vii) the transportation of the nonhuman 
                        primate is in compliance with--
                                    ``(I) all applicable State and 
                                local restrictions regarding the 
                                transport; and
                                    ``(II) all applicable State and 
                                local requirements regarding permits or 
                                health certificates; and
                    ``(D) does not apply'';
                    (C) in paragraph (2) (as added by subparagraph 
                (B))--
                            (i) by striking ``a'' before ``prohibited'' 
                        and inserting ``any'';
                            (ii) by striking ``(3)'' and inserting 
                        ``(4)''; and
                            (iii) by striking ``(2)'' and inserting 
                        ``(3)'';
                    (D) in paragraph (3) (as redesignated by 
                subparagraph (A))--
                            (i) in subparagraph (C)--
                                    (I) in clauses (ii) and (iii), by 
                                striking ``animals listed in section 
                                2(g)'' each place it appears and 
                                inserting ``prohibited wildlife 
                                species''; and
                                    (II) in clause (iv), by striking 
                                ``animals'' and inserting ``prohibited 
                                wildlife species''; and
                            (ii) in subparagraph (D), by striking 
                        ``animal'' each place it appears and inserting 
                        ``prohibited wildlife species'';
                    (E) in paragraph (4) (as redesignated by 
                subparagraph (A)), by striking ``(2)'' and inserting 
                ``(3)''; and
                    (F) in paragraph (6) (as redesignated by 
                subparagraph (A))--
                            (i) by striking ``subsection (a)(2)(C)'' 
                        and inserting ``this subsection''; and
                            (ii) by striking ``2004 through 2008'' and 
                        inserting ``2011 through 2015''.
    (b) Civil Penalties.--Section 4(a) of the Lacey Act Amendments of 
1981 (16 U.S.C. 3373(a)) is amended--
            (1) in paragraph (1), by inserting ``(e),'' after 
        ``subsections (b), (d),''; and
            (2) in paragraph (1), by inserting ``, (e),'' after 
        ``subsection (d)''.
    (c) Criminal Penalties.--Section 4(d) of the Lacey Act Amendments 
of 1981 (16 U.S.C. 3373(d)) is amended--
            (1) in paragraphs (1)(A) and (1)(B) and in the first 
        sentence of paragraph (2), by inserting ``(e),'' after 
        ``subsections (b), (d),'' each place it appears; and
            (2) in paragraph (3), by inserting ``, (e),'' after 
        ``subsection (d)''.
    (d) Effective Date; Regulations.--
            (1) Effective date.--Subsections (a) through (c), and the 
        amendments made by those subsections, shall take effect on the 
        earlier of--
                    (A) the date of promulgation of regulations under 
                paragraph (2); and
                    (B) the expiration of the period referred to in 
                paragraph (2).
            (2) Regulations.--Not later than 180 days after the date of 
        enactment of this Act, the Secretary of the Interior shall 
        promulgate regulations implementing the amendments made by this 
        section.

SEC. 4. APPLICABILITY PROVISION AMENDMENT.

    Section 3 of the Captive Wildlife Safety Act (117 Stat. 2871; 
Public Law 108-191) is amended--
            (1) in subsection (a), by striking ``(a) In General.--
        Section 3'' and inserting ``Section 3''; and
            (2) by striking subsection (b).

SEC. 5. REGULATIONS.

    Section 7(a) of the Lacey Act Amendments of 1981 (16 U.S.C. 
3376(a)) is amended by adding at the end the following:
            ``(3) The Secretary shall, in consultation with other 
        relevant Federal and State agencies, promulgate regulations to 
        implement section 3(e).''.

Ex Output:
Captive Primate Safety Act - Amends the Lacey Act Amendments of 1981 to add nonhuman primates to the definition of "prohibited wildlife species" for purposes of the prohibition against the sale or purchase of such species in interstate or foreign commerce.

Makes it unlawful for a person to import, export, transport, sell, receive, acquire, or purchase a live animal of any prohibited wildlife species in interstate or foreign commerce (i.e., for pet trade purposes). Sets forth exceptions to such prohibition, including, under certain conditions, for: (1) transporting a nonhuman primate to or from a veterinarian, (2) transporting a nonhuman primate to a legally designated caregiver as a result of the death of the preceding owner, and (3) transporting a single primate of the genus Cebus that was obtained from and trained by a charitable organization to assist a permanently disabled individual with a severe mobility impairment.

Sets forth civil and criminal penalties for violations of the requirements of this Act. Extends the authorization of appropriations to carry out such prohibition for FY2011-FY2015.


Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``American Missile Protection Act of 
1998''.

SEC. 2. FINDINGS.

    Congress makes the following findings:
            (1) The threat of weapons of mass destruction delivered by 
        long-range ballistic missiles is among the most serious 
        security issues facing the United States.
                    (A) In a 1994 Executive Order, President Clinton 
                certified, that ``I ... find that the proliferation of 
                nuclear, biological, and chemical weapons (`weapons of 
                mass destruction') and the means of delivering such 
                weapons, constitute an unusual and extraordinary threat 
                to the national security, foreign policy, and economy 
                of the United States, and hereby declare a national 
                emergency to deal with that threat.'' This state of 
                emergency was reaffirmed in 1995, 1996, and 1997.
                    (B) In 1994 the President stated, that ``there is 
                nothing more important to our security and the world's 
                stability than preventing the spread of nuclear weapons 
                and ballistic missiles''.
                    (C) Several countries hostile to the United States 
                have been particularly determined to acquire missiles 
                and weapons of mass destruction. President Clinton 
                observed in January of 1998, for example, that ``Saddam 
                Hussein has spent the better part of this decade, and 
                much of his nation's wealth, not on providing for the 
                Iraqi people, but on developing nuclear, chemical and 
                biological weapons and the missiles to deliver them''.
                    (D) In 1996, the Senate affirmed that, ``it is in 
                the supreme interest of the United States to defend 
                itself from the threat of limited ballistic missile 
                attack, whatever the source.''
            (2) The long-range ballistic missile threat to the United 
        States is increasing.
                    (A) Several adversaries of the United States have 
                stated their intention to acquire intercontinental 
                ballistic missiles capable of attacking the United 
                States.
                            (i) Libyan leader Muammar Qaddafi has 
                        stated, ``If they know that you have a 
                        deterrent force capable of hitting the United 
                        States, they would not be able to hit you. If 
                        we had possessed a deterrent--missiles that 
                        could reach New York--we would have hit it at 
                        the same moment. Consequently, we should build 
                        this force so that they and others will no 
                        longer think about an attack.''
                            (ii) Abu Abbas, the head of the Palestine 
                        Liberation Front, has stated, ``I would love to 
                        be able to reach the American shore, but this 
                        is very difficult. Someday an Arab country will 
                        have ballistic missiles. Someday an Arab 
                        country will have a nuclear bomb. It is better 
                        for the United States and for Israel to reach 
                        peace with the Palestinians before that day.''
                            (iii) Saddam Hussein has stated, ``Our 
                        missiles cannot reach Washington. If we could 
                        reach Washington, we would strike if the need 
                        arose.''
                            (iv) Iranian actions speak for themselves. 
                        Iran's aggressive pursuit of medium-range 
                        ballistic missiles capable of striking Central 
                        Europe--aided by the continuing collaboration 
                        of outside agents--demonstrates Tehran's intent 
                        to acquire ballistic missiles of ever-
                        increasing range.
                    (B) Over 30 non-NATO countries possess ballistic 
                missiles, with at least 10 of those countries 
                developing over 20 new types of ballistic missiles.
                    (C) From the end of World War II until 1980, 
                ballistic missiles were used in one conflict. Since 
                1980, thousands of ballistic missiles have been fired 
                in at least six different conflicts.
                    (D) The clear trend among countries hostile to the 
                United States is toward having ballistic missiles of 
                greater range.
                            (i) North Korea first acquired 300-
                        kilometer range Scud Bs, then developed and 
                        deployed 500-kilometer range Scud Cs, is 
                        currently deploying the 1000-kilometer range 
                        No-Dong, and is developing the 2000-kilometer 
                        range Taepo-Dong 1 and 6000-kilometer range 
                        Taepo-Dong 2, which would be capable of 
                        striking Alaska and Hawaii.
                            (ii) Iran acquired 150-kilometer range CSS-
                        8s, progressed through the Scud B and Scud C, 
                        and is developing the 1300-kilometer range 
                        Shahab-3 and 2000-kilometer range Shahab-4, 
                        which would allow Iran to strike Central 
                        Europe.
                            (iii) Iraq, in a two-year crash program, 
                        produced a new missile, the Al-Hussein, with 
                        twice the range of its Scud Bs.
                            (iv) Experience gained from extending the 
                        range of short- and medium-range ballistic 
                        missiles facilitates the development of 
                        intercontinental ballistic missiles.
                    (E) The technical information, hardware, and other 
                resources necessary to build ballistic missiles are 
                increasingly available and accessible worldwide.
                            (i) Due to advances in information 
                        technology, a vast amount of technical 
                        information relating to ballistic missile 
                        design, much of it formerly classified, has 
                        become widely available and is increasingly 
                        accessible through the Internet and other 
                        distribution avenues.
                            (ii) Components, tools, and materials to 
                        support ballistic missile development are 
                        increasingly available in the commercial 
                        aerospace industry.
                            (iii) Increasing demand for satellite-based 
                        telecommunications is adding to the demand for 
                        commercial Space Launch Vehicles, which employ 
                        technology that is essentially identical to 
                        that of intercontinental ballistic missiles. As 
                        this increasing demand is met, the technology 
                        and expertise associated with space launch 
                        vehicles also proliferate.
                    (F) Russia and China have provided significant 
                technical assistance to rogue nation ballistic missile 
                programs, accelerating the pace of those efforts. In 
                June of 1997, the Director of Central Intelligence, 
                reporting to Congress on weapons of mass destruction-
                related equipment, materials, and technology, stated 
                that ``China and Russia continued to be the primary 
                suppliers, and are key to any future efforts to stem 
                the flow of dual-use goods and modern weapons to 
                countries of concern.''
                    (G) Russia and China continue to engage in missile 
                proliferation.
                            (i) Despite numerous Russian assurances not 
                        to assist Iran with its ballistic missile 
                        program, the Deputy Assistant Secretary of 
                        State for Nonproliferation testified to the 
                        Senate, that ``the problem is this: there is a 
                        disconnect between those reassurances, which we 
                        welcome, and what we believe is actually 
                        occurring.''
                            (ii) Regarding China's actions to 
                        demonstrate the sincerity of its commitment to 
                        nonproliferation, the Director of Central 
                        Intelligence testified to the Senate on January 
                        28, 1998, that, ``the jury is still out on 
                        whether the recent changes are broad enough in 
                        scope and whether they will hold over the 
                        longer term. As such, Chinese activities in 
                        this area will require continued close 
                        watching.''
                    (H) The inability of the United States to defend 
                itself against weapons of mass destruction delivered by 
                long-range ballistic missile provides additional 
                incentive for hostile nations to develop long-range 
                ballistic missiles with which to threaten the United 
                States. Missiles are widely viewed as valuable tools 
                for deterring and coercing a vulnerable United States.
            (3) The ability of the United States to anticipate future 
        ballistic missile threats is questionable.
                    (A) The Intelligence Community has failed to 
                anticipate many past technical innovations (for 
                example, Iraq's extended-range Al-Hussein missiles and 
                its development of a space launch vehicle) and outside 
                assistance enables rogue states to surmount traditional 
                technological obstacles to obtaining or developing 
                ballistic missiles of increasing range.
                    (B) In June of 1997, the Director of Central 
                Intelligence reported to Congress that ``many Third 
                World countries--with Iran being the most prominent 
                example--are responding to Western counter-
                proliferation efforts by relying more on legitimate 
                commercial firms as procurement fronts and by 
                developing more convoluted procurement networks.''
                    (C) In June of 1997, the Director of Central 
                Intelligence stated to Congress that ``gaps and 
                uncertainties preclude a good projection of exactly 
                when `rest of the world' countries will deploy ICBMs.''
                    (D) In 1997, the Director of Central Intelligence 
                testified that Iran would have a medium-range missile 
                by 2007. One year later the Director stated, ``since I 
                testified, Iran's success in getting technology and 
                materials from Russian companies, combined with recent 
                indigenous Iranian advances, means that it could have a 
                medium-range missile much sooner than I assessed last 
                year.'' Department of State officials have testified 
                that Iran could be prepared to deploy such a missile as 
                early as late 1998, nine years earlier than had been 
                predicted one year before by the Director of Central 
                Intelligence.
            (4) The failure to prepare adequately for long-range 
        ballistic missile threats could have severe national security 
        and foreign policy consequences for the United States.
                    (A) An attack on the United States by a ballistic 
                missile equipped with a weapon of mass destruction 
                could inflict catastrophic death or injury to citizens 
                of the United States and severe damage to their 
                property.
                    (B) A rogue state's ability to threaten the United 
                States with an intercontinental ballistic missile may 
                constrain the United States' options in dealing with 
                regional threats to its interests, deter the United 
                States from taking appropriate action, or prompt allies 
                to question United States security guarantees, thereby 
                weakening alliances of the United States and the United 
                States' world leadership position.
            (5) The United States must be prepared for rogue nations 
        acquiring long-range ballistic missiles armed with weapons of 
        mass destruction.
                    (A) In its resolution of ratification for the START 
                II Treaty, the United States Senate declared that 
                ``because deterrence may be inadequate to protect the 
                United States against long-range ballistic missile 
                threats, missile defenses are a necessary part of new 
                deterrent strategies.''
                    (B) In September of 1994, Secretary of Defense 
                Perry stated that in the post-Cold War era, ``we now 
                have opportunity to create a new relationship based not 
                on MAD, not on Mutual Assured Destruction, but rather 
                on another acronym, MAS, or Mutual Assured Safety.''
                    (C) On February 12, 1997, the Under Secretary of 
                Defense for Policy testified to the Senate that ``I and 
                the administration are quite willing to acknowledge 
                that if we saw a rogue state, a potential proliferant, 
                beginning to develop a long-range ICBM capable of 
                reaching the United States, we would have to give very, 
                very serious attention to deploying a limited national 
                missile defense.''
            (6) The United States has no defense deployed against 
        weapons of mass destruction delivered by long-range ballistic 
        missiles and no policy to deploy such a national missile 
        defense system.

SEC. 3. NATIONAL MISSILE DEFENSE POLICY.

    It is the policy of the United States to deploy as soon as is 
technologically possible an effective National Missile Defense system 
capable of defending the territory of the United States against limited 
ballistic missile attack (whether accidental, unauthorized, or 
deliberate).

Ex Output:
American Missile Protection Act of 1998 - States as U.S. policy to deploy as soon as technologically possible an effective National Missile Defense system capable of defending U.S. territory against limited ballistic missile attack (whether accidental, unauthorized, or deliberate).


Ex Input:
SECTION 1. ACTION PLAN ON RECOMMENDATIONS FOR CHANGES UNDER MEDICARE 
              AND MEDICAID TO PREVENT OPIOIDS ADDICTIONS AND ENHANCE 
              ACCESS TO MEDICATION-ASSISTED TREATMENT.

    (a) In General.--Not later than January 1, 2019, the Secretary of 
Health and Human Services (in this section referred to as the 
``Secretary''), in collaboration with the Pain Management Best 
Practices Inter-Agency Task Force convened under section 101(b) of the 
Comprehensive Addiction and Recovery Act of 2016 (Public Law 114-198), 
shall develop an action plan that provides recommendations described in 
subsection (b).
    (b) Action Plan Components.--Recommendations provided under the 
action plan under subsection (a) shall include recommendations on the 
following:
            (1) Recommendations on changes to the Medicare program 
        under title XVIII of the Social Security Act and the Medicaid 
        program under title XIX of such Act that would enhance coverage 
        and reimbursement under such programs of all medication-
        assisted treatment approved by the Food and Drug Administration 
        for the treatment of opioid addiction and other therapies that 
        manage chronic and acute pain and treat and minimize risk of 
        opioid addiction, including recommendations on changes to the 
        Medicare prospective payment system for hospital inpatient 
        department services under section 1886(d) of such Act (42 
        U.S.C. 1395ww(d)) and the Medicare prospective payment system 
        for hospital outpatient department services under section 
        1833(t) of such Act (42 U.S.C. 1395l(t)) that would allow for 
        separate reimbursement for such therapies to encourage 
        development and adoption of such therapies, if medically 
        appropriate.
            (2) Recommendations for payment and service delivery models 
        to be tested by the Center for Medicare and Medicaid Innovation 
        and other federally authorized demonstration projects, 
        including value-based models, that may encourage the use of 
        appropriate medication-assisted treatment approved by the Food 
        and Drug Administration for the treatment of opioid addiction 
        and other therapies that manage chronic and acute pain and 
        treat and minimize risk of opioid addiction.
            (3) Recommendations for data collection that can facilitate 
        research and policy making regarding prevention of opioid 
        addiction and coverage and reimbursement under the Medicare 
        program and the Medicaid program of appropriate opioid 
        addiction treatments.
            (4) Recommendations for provider education that can expand 
        patient access to the full range of medication-assisted 
        treatment approved by the Food and Drug Administration for the 
        treatment of opioid addiction and other therapies that manage 
        chronic and acute pain and treat and minimize risk of opioid 
        addiction.
            (5) Recommendations for policies under the Medicare program 
        and under the Medicaid program that can expand access for 
        rural, or medically underserved communities to the full range 
        of medication-assisted treatment approved by the Food and Drug 
        Administration for the treatment of opioid addiction and other 
        therapies that manage chronic and acute pain and treatment and 
        minimize risk of opioid addiction.
    (c) Stakeholder Meetings.--
            (1) In general.--Beginning not later than 3 months after 
        the date of the enactment of this Act, the Secretary shall 
        convene a public stakeholder meeting to solicit public comment 
        on the components of the action plan recommendations described 
        in subsection (b).
            (2) Participants.--Participants of meetings described in 
        paragraph (1) shall include representatives from the Food and 
        Drug Administration and National Institutes of Health, 
        biopharmaceutical industry members, medical researchers, health 
        care providers, the medical device industry, the Medicare 
        program, the Medicaid program, and patient advocates.
    (d) Request for Information.--Not later than 3 months after the 
date of the enactment of this section, the Secretary shall issue a 
request for information seeking public feedback regarding ways in which 
the Centers for Medicare & Medicaid Services can help address the 
opioid crisis through the development of and application of the action 
plan.
    (e) Report to Congress.--Not later than March 1, 2019, the 
Secretary shall submit to Congress, and make public, a report that 
includes a summary of steps taken under the action plan, 
recommendations that have emerged under the action plan, and the 
Secretary's planned next steps with respect to the action plan.
    (f) Definition of Medication-Assisted Treatment.--In this section, 
the term ``medication-assisted treatment'' includes opioid treatment 
programs, behavioral therapy, and medications to treat substance abuse 
disorder.

SEC. 2. REPORT ON COVERAGE, CODING, AND REIMBURSEMENT POLICIES UNDER 
              MEDICARE.

    (a) In General.--Not later than 1 year after the date of the 
enactment of this Act, the Secretary of Health and Human Services (in 
this section referred to as the ``Secretary'') shall--
            (1) identify--
                    (A) medical devices that are non-opioid based 
                treatments approved by the Food and Drug Administration 
                for the management of acute pain and chronic pain;
                    (B) medical devices that are non-opioid based 
                treatments approved by the Food and Drug Administration 
                that monitor substance use withdrawal and prevent 
                overdoses of controlled substances; and
                    (C) medical devices that are non-opioid based 
                treatments approved by the Food and Drug Administration 
                that treat substance use disorder; and
            (2) submit to the Committee on Finance of the Senate and 
        the Committees on Ways and Means and Energy and Commerce of the 
        House of Representatives, and publish on a public Internet 
        website of the Department of Health and Human Services, a 
        report containing recommendations on ways to encourage the use 
        of such medical devices by individuals entitled to benefits 
        under part A of title XVIII of the Social Security Act and 
        enrolled under part B of such title (including individuals 
        enrolled in a Medicare Advantage plan under part C of such 
        title or in a prescription drug plan under part D of such 
        title) and individuals enrolled under a State plan under title 
        XIX of such Act.
    (b) Contents.--The report under subsection (a) shall include an 
analysis of the following, with respect to the Medicare program under 
title XVIII of the Social Security Act and the Medicaid program under 
title XIX of such Act:
            (1) Various opioid alternatives for pain treatment that are 
        covered under such programs, that are not covered under such 
        programs, that have limited coverage under such program, or 
        with respect to which there are payment barriers under such 
        programs.
            (2) Various medical devices that monitor substance use 
        withdrawal and prevent overdose of controlled substances that 
        are covered so covered, that are not so covered, that have such 
        limited coverage, or with respect to which there are such 
        payment barriers.
            (3) Various medical devices that treat substance use 
        disorder and opioid use disorder that are so covered, that are 
        not so covered, that have such limited coverage, or with 
        respect to which there are such payment barriers.
            (4) Access to payment codes used by health care providers 
        that promote alternative options for pain management therapies 
        without the use of opioids, including minimally invasive pain 
        therapies.
            (5) Ways to improve communications between Medicare 
        prescription drug plans and Medicare Advantage plans, Medicare 
        and Medicaid health care providers, and Medicare beneficiaries 
        and Medicaid beneficiaries on the potential harm associated 
        with the use of opioids and other controlled substances, 
        including the need to safely store and dispose of supplies 
        relating to the use of opioids and other controlled substances.

Ex Output:

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to develop an action plan to provide recommendations on changes to the Medicare and Medicaid programs to enhance: (1) the treatment and prevention of opioid addiction, and (2) the coverage and reimbursement of medication-assisted treatment for opioid addiction. The CMS must convene a stakeholder meeting to solicit public comment on the action plan.